CVS Coram: Revolutionizing Pharmacy With Unmatched Convenience - magento2
Webin an effort to develop its specialty pharmacy business, cvs caremark (nyse:cvs) unveiled a $2. 1 billion deal on wednesday to acquire the specialty infusion.
Webdrugstore chain cvs caremark corp.
Completed its $2. 1 billion acquisition of the drug infusion business coram llc, and it expects the deal to start helping earnings.
Recommended for you
🔗 Related Articles You Might Like:
The Ultimate Job Board: Aetna's Exclusive Remote Hiring Event Pals Quizlet Prison In Omaha Nebraska📸 Image Gallery
You may also like